Abstract
Background Short inter-pregnancy interval is when the time elapsed between the dates of birth of the preceding child and the conception date of the current pregnancy is < 24 months. Despite its direct effects on the perinatal and maternal outcomes, there is a paucity of evidence on its prevalence and determinant factors, particularly in Ethiopia. Therefore, this study assessed the prevalence and associated factors of short inter-pregnancy interval among pregnant women in Debre Berhan town, Northern Ethiopia.
Methods A community based cross sectional study was conducted among a randomly selected 496 pregnant women in Debre Berhan town from February 9 to March 9, 2020. The data was collected by using interviewer administered questionnaire and analyzed using STATA (14.2) statistical software. To identify the predictors of short inter-pregnancy interval, multivariable binary logistic regression was fitted and findings are presented using adjusted odds ratio (AOR) with 95% confidence interval (CI).
Result The overall prevalence of short inter-pregnancy interval (<24 months) among pregnant women was 205 (40.9%). Being over 30 years of age at first birth (AOR=3.50; 95% CI: 2.12-6.01), non-use of modern contraceptive (AOR=2.51; 95% CI: 1.23-3.71), duration of breast feeding for less than 12 months (AOR= 2.62; 95% CI: 1.32-5.23), parity above four (AOR=0.31; 95% CI: 0.05-0.81), and unintended pregnancy (AOR= 5.42; 95% CI: 3.34-9.22) were independently associated factors with short inter-pregnancy interval.
Conclusion Despite the family planning and other public health intervention tried in the country, the prevalence of short inter-pregnancy interval in this study was high. Therefore, it implies that increasing contraceptive use and encouraging optimal breast feeding might help in the efforts made to avert the problem.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Debre Berhan University (www.dbu.edu.et) funded this study. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight boudy that provided approval or exemption for the research described are given below:
Ethical clearance was obtained from the Ethical Review Committee of the Debre Berhan University. The approval number was "Sop DBUMF 009." The informed written consent was obtained from each respondent. Personal identifiers such as name was not mentioned in the questionnaire.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All the supplementary data can be obtained from the corresponding author up on request.
